Recently, BAP1 or SF3B1 mutations have been found to occur alongside GNAQ and GNA11 in approximately 20% of cases of unequivocally malignant blue nevus-like melanoma, suggesting that this is a late mutational event [52]. Here, SF3B1 is linked to melanoma.